Myeloablative haploidentical t‐cell replete hematopoietic cell transplantation with post‐transplant cyclophosphamide in high‐risk hematological malignancies: Bending the learning curve in a middle‐income setting
ADVANCES IN CELL AND GENE THERAPY · 2021
DOI: 10.1002/acg2.106 ↗Kurz gefasst
Fachartikel in der Zeitschrift ADVANCES IN CELL AND GENE THERAPY, 2021. Verfasst von Sanket P. Shah und 11 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shah, S. P., Radhakrishnan, V. S., Jaishetwar, G. S., Sukumaran, R. K., Kumar, J., Bhave, S. J., Roychowdhury, M., Chaudhuri, S., Mishra, D. K., Nair, R., Krishnan, S., & Chandy, M. (2021). Myeloablative haploidentical t‐cell replete hematopoietic cell transplantation with post‐transplant cyclophosphamide in high‐risk hematological malignancies: Bending the learning curve in a middle‐income setting. ADVANCES IN CELL AND GENE THERAPY. https://doi.org/10.1002/acg2.106
Vancouver
Shah SP, Radhakrishnan VS, Jaishetwar GS, Sukumaran RK, Kumar J, Bhave SJ, et al. Myeloablative haploidentical t‐cell replete hematopoietic cell transplantation with post‐transplant cyclophosphamide in high‐risk hematological malignancies: Bending the learning curve in a middle‐income setting. ADVANCES IN CELL AND GENE THERAPY. 2021. doi:10.1002/acg2.106
BibTeX
@article{Shah2021,
author = {Shah, Sanket P. and Radhakrishnan, Vivek S. and Jaishetwar, Ganesh S. and Sukumaran, Reghu K. and Kumar, Jeevan and Bhave, Saurabh J. and Roychowdhury, Mita and Chaudhuri, Sayak and Mishra, Deepak K. and Nair, Reena and Krishnan, Shekhar and Chandy, Mammen},
title = {Myeloablative haploidentical t‐cell replete hematopoietic cell transplantation with post‐transplant cyclophosphamide in high‐risk hematological malignancies: Bending the learning curve in a middle‐income setting},
journal = {ADVANCES IN CELL AND GENE THERAPY},
year = {2021},
doi = {10.1002/acg2.106}
}
EUVIMED